Insider: Tanguler Tolga EVP, Chief Commercial Officer - ALNYLAM PHARMACEUTICALS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 36,398 | 0 | 36,398 |
| Value | $11,605,502.30 | $0.00 | $11,605,502.30 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2026 | DDS | 102 | Direct | COM | $320.01 | $32,641.02 | 36,398 |
| 03/04/2026 | DDS | 106 | Direct | COM | $319.03 | $33,817.18 | 36,500 |
| 03/04/2026 | DDS | 208 | Direct | COM | $325.67 | $67,739.36 | 34,297 |
| 03/04/2026 | DDS | 289 | Direct | COM | $321.82 | $93,005.98 | 35,894 |
| 03/04/2026 | DDS | 215 | Direct | COM | $320.81 | $68,974.15 | 36,183 |
| 03/04/2026 | DDS | 767 | Direct | COM | $323.84 | $248,385.28 | 34,777 |
| 03/04/2026 | DDS | 272 | Direct | COM | $324.88 | $88,367.36 | 34,505 |
| 03/04/2026 | DDS | 350 | Direct | COM | $323.01 | $113,053.50 | 35,544 |
| 03/02/2026 | DDS | 258 | Direct | COM | $325.63 | $84,012.54 | 37,809 |
| 03/02/2026 | DDS | 90 | Direct | COM | $324.65 | $29,218.50 | 38,067 |
| 03/02/2026 | DDS | 47 | Direct | COM | $323.62 | $15,210.14 | 38,157 |
| 03/02/2026 | DDS | 329 | Direct | COM | $327.67 | $107,803.43 | 37,088 |
| 03/02/2026 | DDS | 392 | Direct | COM | $326.81 | $128,109.52 | 37,417 |
| 03/02/2026 | DDS | 94 | Direct | COM | $331.93 | $31,201.42 | 36,643 |
| 03/02/2026 | DDS | 81 | Direct | COM | $330.85 | $26,798.85 | 36,737 |
| 03/02/2026 | DDS | 170 | Direct | COM | $329.71 | $56,050.70 | 36,818 |
| 03/02/2026 | DDS | 100 | Direct | COM | $328.71 | $32,871.00 | 36,988 |
| 03/02/2026 | DDS | 37 | Direct | COM | $332.64 | $12,307.68 | 36,606 |
| 02/13/2026 | DDS | 1,959 | Direct | COM | $310.08 | $607,448.29 | 31,769 |
| 01/12/2026 | DDS | 85 | Direct | COM | $359.14 | $30,526.90 | 30,812 |
| 01/12/2026 | DDS | 155 | Direct | COM | $360.22 | $55,834.10 | 30,657 |
| 01/12/2026 | DDS | 98 | Direct | COM | $361.45 | $35,422.10 | 30,559 |
| 01/12/2026 | DDS | 73 | Direct | COM | $362.38 | $26,453.74 | 30,486 |
| 01/12/2026 | DDS | 123 | Direct | COM | $358.18 | $44,056.14 | 30,897 |
| 01/12/2026 | DDS | 39 | Direct | COM | $353.95 | $13,804.05 | 31,199 |
| 1 2 3 4 5 6 Next Last You are at page 1 of 6 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research